Model-Based Drug-Development (MBDD) - WorldPharma 2010

More documents

Recommendations

Info

Separating Systems & Drug InformationSystemsDataDrugDataTrialDesignMechanisticIVIVE &PBPKPopulation PK (/PD)&Covariates of ADME&Study Design
Creating Virtual Populations.... proposes that new technologies will enable the adoption of virtual R&D; andby operating in a more connected world, the industry in collaboration withresearchers, governments, healthcare payers and providers, can address thechanging needs of society more effectively(Old)Top-DownModellingvsJune 2008(New)Bottom-UpModelling
Page 4: Model-based Drug Development (MBDD)
Page 8 and 9: The Need for Systems ApproachClinic
Page 12 and 13: Building Virtual Man vs Populations
Page 14 and 15: Incidence per 100,000% of controlGF
Page 16 and 17: Morbid Obesity: BPD-DS & GBPBPD-DS:
Page 18 and 19: Is that enough?Sometimes not; hence
Page 20 and 21: Highly Non-Linear Systems: OF250200
Page 22: Correspondence for full set of slid

Model-Based Drug-Development (MBDD) - WorldPharma 2010

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?